• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

9am.Health Nabs $16M to Expand Virtual Diabetes Clinic Nationwide

by Fred Pennic 04/13/2022 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
9am.Health Nabs $16M to Expand Virtual Diabetes Clinic Nationwide

What You Should Know:

– 9am.health, a San Diego, CA-based virtual diabetes clinic that delivers personalized, affordable, and compassionate care directly to consumers raises $16M in Series A funding co-led by 7Wire Ventures and Human Capital and included participation from new investors StartUp Health, Leaps by Bayer, and existing investors Define Ventures and Founders Fund. The latest round brings its total funding to date to nearly $20M.

– Innovative virtual care provider is now available in 47 states and D.C. directly to consumers, providing personalized treatment plans to people with prediabetes and type 2 diabetes

Comprehensive Virtual Diabetes Destination

Prediabetes and type 2 diabetes are two of the most prevalent chronic conditions in the U.S., collectively costing the nation hundreds of billions of dollars each year and creating thousands in medical expenses for individuals. Both populations are at significant risk of developing severe long-term health issues if their condition isn’t managed. Studies also have shown that people with diabetes are at higher risk of developing serious COVID-19 illness.

Founded by Frank Westermann, Anton Kittelberger, Paul Geevarghese, and Bernhard Schandl, 9am.health has rapidly expanded its services over the past few months. 9am.health provides a subscription-based direct-to-consumer diabetes treatment platform that includes home delivery of Rx for prediabetes and type 2 diabetes — along with common comorbidities — while also providing at-home testing, screening (glucose monitoring kits) and 24/7 virtual care team support.

The comprehensive subscription-based service that includes access to at-home diagnostic lab tests, blood glucose monitoring kits and physician-prescribed medications for prediabetes, type 2 diabetes and commonly associated conditions – all delivered directly and discreetly to patients’ homes. All members get personalized treatment plans that come with unlimited access to the 9am.health medical care team that can answer any patient need. 9am.health also provides non-members with at-home diabetes and prediabetes screenings at low costs.

Now 9am.health is planning to grow its DTC presence while also expanding to serve the self-insured employer market. To help enable this expansion, 9am.health will use the new funding to grow its clinical and pharmacy services to include more medications and build out an ecosystem of medical device integrations and platform partners nationwide.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: diabetes, Medical Device, Partners, Pharmacy, risk, Startup Health, Type 2 Diabetes, Virtual Care, Virtual Diabetes

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |